Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Blocking casein kinase 1 in skin cells can help melanocyte precursors move better, potentially helping with conditions like vitiligo or gray hair.

Blocking a key energy pathway in human hair follicles can trigger stress responses that stop cell growth.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Stress-related hair loss was reversed with a special medication.

Blocking DPP4 can help activate hair growth and improve hair regeneration.

Brain-made chemicals can control nerve cell function differently in various parts of a mouse's brain, which may help us understand neurological conditions.

Three compounds from Dadap leaves may help treat hair loss.

Oenocarpus bataua vegetable oil may help reduce hair loss by affecting a key gene pathway.

Laser treatment can inhibit hair growth and different hair colors reach different temperatures when lasered.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

All-trans-retinoic acid stops mink hair growth by affecting cell growth and causing cell death.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Low-dose oral minoxidil improved hair growth when topical treatments failed.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Erlotinib can cause nonscarring hair loss and itchy skin.

Sorafenib can cause a unique skin reaction.

Y-27632 helps hair follicle stem cells grow and keep their abilities.

Sorafenib often causes skin side effects, indicating effective cancer treatment.

Some hair loss drugs can cause a unique type of hair loss that resembles both psoriasis and alopecia.

DFMO may help control hair growth and treat cancer.

The inhibitor affects androgen metabolism but not ovarian function.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

The FDA approved a new Pfizer drug for hair loss in teens.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

Access to JAK inhibitor therapy for alopecia areata patients is difficult, especially for racial minorities.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.